Goals and Objectives:

  • Developing novel drugs based on patient’s omics and biomarker data for Precision Cancer Medicine
  • Discovering new treatments for rare cancers and neurodegenerative diseases by repurposing approved medications
  • Developing novel liposomal based drug delivery formulations to improve therapeutic index of both experimental and clinically approved drugs
  • Applying preclinical-ADME drug design strategies for creating drug-like small molecules for preclinical IND enabling studies
Research Model New Paradigm Shift in Treatment